| Follow Us:

Innovation & Job News

osu and cleveland clinic join forces to accelerate medical commercialization and jobs creation

The Ohio State University’s Technology Commercialization and Knowledge Transfer Office (TCO) and Cleveland Clinic Innovations recently formed a special alliance with the goal of helping move Ohio into the forefront of medical innovation and enhance job creation in the state.

“Nationally, this is one of the few alliances of this kind between prominent academic medical centers, putting Ohio in a leadership position for the commercialization of medical technology,” according to Brian Cummings, OSU’s vice president of technology commercialization.

Efforts will focus on improving and extending the lives of patients, and innovations will come in many forms, such as medical devices, patient services, new medical software systems, consumer products and startup companies, Cummings explains.
“This partnership holds enormous potential for Ohio to reshape the future of medicine,” says Ohio State President E. Gordon Gee in a news release.

The two organizations will be sharing and using their comprehensive technology and commercialization service infrastructures to develop and deploy new medical innovations generated by researchers, physicians, faculty and administrative staff at both institutions.

“Our first step going forward is to assess each other’s assets, available resources, unique programs and intellectual property portfolios and to begin to analyze the overlaps and gaps where we can assist each other,” Cummings says.

Cummings cites neuromodulation as an important innovation for the new partnership to explore. “Neuromodulation is one of the hottest areas of research and breakthrough innovation in current medical practice,” he says. "It has the potential through electrical stimulation to literally turn diseases off and on."

"Dr. Ali Rezai is a leader in this field and currently works at the Ohio State Wexner Medical Center but started his work at the Cleveland Clinic, where he has built up a large portfolio of high-value companies and patents," Cummings adds. "Using the Clinic’s existing intellectual property and the clinical capabilities of Dr. Rezai’s current work at Ohio State should lead to a string of joint innovations and a host of new companies."

Source: Brian Cummings
Writer: Lynne Meyer
Share this page